Dr. James Mark, MD

Urologic Oncology •  Male • Age 37

  4 Reviews

Dr. James Mark, MD is an urologic oncology specialist in Philadelphia, PA and has been practicing for 3 years. He specializes in urologic oncology and urology.


Locations

Jefferson at the Navy Yard

New Patient?
(215) 259-5822
1
  • Call
  • Fax
  • Hours
    • Mon: closed
    • Tue: 8:00am - 4:00pm
    • Wed: closed
    • Thu: 8:00am - 4:00pm
    • Fri: closed
    • Sat: closed
    • Sun: closed
  • Directions
2
  • Call
  • Fax
  • Hours
    • Mon: 8:00am - 4:00pm
    • Tue: 8:00am - 4:00pm
    • Wed: 8:00am - 4:00pm
    • Thu: 8:00am - 4:00pm
    • Fri: 8:00am - 4:00pm
    • Sat: closed
    • Sun: closed
  • Directions

Dr. Mark's Reviews

Likelihood to recommend Dr. Mark

4.0

Based on 4 reviews

5 Stars
75%
(3)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
25%
(1)

Leave a review

How likely are you to recommend
Dr. Mark?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Mark's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. James Mark, MD
RecentHighestLowestMost Helpful
Reply
I have the utmost confidence in Dr. Mark's medical/surgical expertise. From my first visit, I've also been impressed with his relaxed and calming style. He's performed one successful surgery to-date, one (or two) to go. I feel assured that I am in excellent hands.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. James Mark, MD?
Reply
Very disappointed with the urology department. The "team" had no concern for patient's mental state. Very dismissive. Even the staff nurses at TJUH expressed concern related to the lack of empathy or professionalism
Was this helpful?
thumbs up icon option2
thumbs down icon option4
Hi, we appreciate your honest review. We would...Read More
×Post a ResponseAre you Dr. James Mark, MD?
Reply
best care,very attentive and personal..
Was this helpful?
thumbs up icon option1
thumbs down icon option
×Post a ResponseAre you Dr. James Mark, MD?
Reply
Dr. Mark is a great doctor. I would and will recommend him always. He is an exceptional urologist and an expert in the Davinci robotics. I am basing this on our experience with a serious problem that my husband had. Dr Mark thoroughly examined my husband, requested the needed tests and explained the results to us in a way that we understood. Dr Mark found that surgery was needed. He took the time to explain exactly what he was going to do. He is a phenomenal dr and great human being.
Was this helpful?
thumbs up icon option2
thumbs down icon option2
×Post a ResponseAre you Dr. James Mark, MD?

Leave a review

How was your experience with Dr. Mark?

Insurance Check

Search for your insurance provider

Dr. Mark accepts most major insurance plans.

Dr. Mark has indicated that he accepts most major insurance carriers

Accepted insurance can change. Please double-check when making an appointment.

(215) 259-5822Find providers who accept this insurance

Background Check

Healthgrades does not collect malpractice claims information for Pennsylvania
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Mark's experience treating your condition or procedure

Dr. Mark's Top Procedures and Conditions

Treatment Frequency
Cancer
normal
normal

Treatment Frequency

Dr. Mark treats Cancer more than 68% of his peers

Dr. Mark treats this condition more than 68% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Cystourethroscopy and Transurethral Resection of Bladder Neck
normal
normal

Treatment Frequency

Dr. Mark performs Cystourethroscopy and Transurethral Resection of Bladder Neck more than 62% of his peers

Dr. Mark performs this procedure more than 62% of his peers

Hydronephrosis
normal
normal

Treatment Frequency

Dr. Mark treats Hydronephrosis more than 58% of his peers

Dr. Mark treats this condition more than 58% of his peers

Dr. Mark's conditions and procedures:

  • Adrenal Gland Cancer
  • Adrenalectomy
  • Adrenalectomy With Robotic Assistance
  • Bladder Cancer
  • Bladder Diverticulum
  • Bladder Exstrophy Repair
  • Bladder Stones
  • Bladder Surgery
  • Cancer
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Complete Nephrectomy With Robotic Assistance
  • Cystectomy
  • Cystometry
  • Cystourethroscopy and Transurethral Resection of Bladder Neck
  • da Vinci® Nephrectomy
  • da Vinci® Robotic Surgery
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Genitourinary Cancers
  • Hydronephrosis
  • Kidney and Ureter Removal
  • Kidney Cancer
  • Kidney Removal
  • Kidney Stone Removal, Closed
  • Kidney Surgery
  • Laparoscopic Live Donor Nephrectomy
  • Laparoscopic Nephrectomy
  • Lymph Node Biopsy or Excision
  • Lymph Node Resection
  • Male Genital System Cancer
  • Male Genitourinary Cancer
  • Metastatic Cancer
  • Orchiectomy
  • Papillary Renal Cell Carcinoma
  • Partial Cystectomy With Robotic Assistance
  • Partial Nephrectomy
  • Partial Nephrectomy With Robotic Assistance
  • Penile Cancer
  • Percutaneous Destruction of Kidney Lesion
  • Peyronie's Disease
  • Polyuria
  • Primary Prostate Cancer
  • Prostate Biopsy
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Prostate Removal
  • Prostatectomy With Robotic Assistance
  • Radical Cystectomy
  • Radical Cystectomy and Prostate Removal
  • Radical Nephrectomy
  • Radical Prostate Removal
  • Radical Prostate Removal, Laparoscopic
  • Radical Retropubic Prostate Removal
  • Renal Biopsy
  • Renal Cell Cancer
  • Sentinel Node Biopsy
  • Soft Tissue Mass Biopsy
  • Squamous Cell Carcinoma
  • Surgical Biopsy
  • Testicular Cancer
  • Thoracentesis
  • Total Cystectomy With Robotic Assistance
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Transurethral Resection of Bladder Tumor (TURBT)
  • TURP (Transurethral Resection of Prostate) or Laser Destruction of Prostate
  • TURP (Transurethral Resection of the Prostate)
  • Ureteral Cancer
  • Ureteral Stones
  • Ureteral Stricture or Kinking
  • Ureterscopies
  • Urethral Stricture
  • Urinary Stone Removal (Litholapaxy)
  • Urinary Tract Cancer
  • Vasectomy
  • Wound Repair

About Me

Biography

Dr. James Mark, MD is an urologic oncology specialist in Philadelphia, PA and has been practicing for 3 years. He specializes in urologic oncology and urology.

Specialties

  • Urologic Oncology
  • Urology

Board Certifications

Education

2016
Carolinas Medical Center
Fellowship Hospital
2015
Thomas Jefferson University
Residency Hospital
2010
Thomas Jefferson University
Internship Hospital
2009
St Louis Univ Sch Of Med
Medical School
2005
University of Missouri
Undergraduate School
2016
2015
2010
2009
2005

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Mark treats patients.

Learn more

73% Patient experience rating, 4% higher than the national average

  • America's 250 Best Hospitals Award™ (2019, 2018, 2017)
  • America's 50 Best Hospitals Award™ (2019)
  • America's 100 Best Hospitals Award™ (2018, 2017)
  • Patient Safety Excellence Award™ (2019, 2018)

70% Patient experience rating, 1% higher than the national average

  • Patient Safety Excellence Award™ (2019, 2018)